Mazdutide 10 mg

Dragon Pharma Mazdutide

For athletes, bodybuilders, and fitness enthusiasts focused on body composition, metabolic regulation, and appetite control, Mazdutide represents a significant advancement in peptide research. As a dual agonist targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, Mazdutide offers a unique mechanism for investigating metabolic pathways, satiety signaling, and energy homeostasis. This Dragon Pharma Mazdutide 10mg offering delivers high-purity lyophilized powder in a sterile 2mL vial, providing researchers with a premium compound for advanced metabolic and body composition research.

Mazdutide functions through dual receptor activation, combining the appetite-suppressing effects of GLP-1 agonism with the complementary metabolic benefits of GIP receptor activation. This dual mechanism results in enhanced glycemic control, delayed gastric emptying, and potent appetite regulation. Research published in the NIH PubMed database demonstrates that dual GLP-1/GIP agonists produce superior metabolic outcomes compared to single-receptor agonists, with Phase 2 clinical trials showing significant reductions in body weight and improved insulin sensitivity. These findings position Mazdutide as a leading compound for research into obesity, metabolic syndrome, and body composition optimization.

The relevance of Mazdutide to athletic performance and physique enhancement is substantial. For bodybuilders navigating cutting phases, the ability to maintain a caloric deficit while preserving lean muscle mass is critical. Mazdutide's potent appetite-suppressing effects can help athletes adhere to caloric restrictions without the psychological burden of constant hunger. Additionally, its effects on insulin sensitivity and glucose metabolism support stable energy levels during training, reducing the risk of energy crashes that can compromise workout intensity. The compound's impact on gastric emptying also helps athletes maintain satiety between meals, supporting consistent nutrient timing strategies.

Quality assurance is paramount in peptide research. Each batch of our Mazdutide 10 mg inventory undergoes rigorous third-party HPLC-MS testing to verify purity and dosage. The most recent batch (September 2024) tested at 9.11 mg with batch number #MZDHD7. This level of transparency and quality control ensures that researchers can trust the integrity of the compounds they are investigating.

For bodybuilders and strength athletes seeking advanced metabolic research tools, Mazdutide offers a sophisticated approach to studying appetite regulation, insulin sensitivity, and body composition. Its dual-agonist mechanism represents a significant evolution from first-generation GLP-1 agonists, providing more comprehensive metabolic modulation. Whether investigating strategies for contest preparation, metabolic health optimization, or sustainable weight management, Dragon Pharma's Mazdutide delivers the purity, potency, and reliability required for serious research into next-generation metabolic pathways.

Note: This product is intended for laboratory research and scientific investigation purposes only. Not for human consumption or veterinary use.

Product Specifications

Usage Guidelines

Mazdutide is supplied as a sterile lyophilized powder and must be reconstituted with bacteriostatic water or sterile saline prior to research use. For optimal stability, gently swirl the vial after adding the diluent—do not shake vigorously. Standard research protocols involve reconstituting the 10mg peptide with 2-4mL of bacteriostatic water, yielding a concentration of 2.5-5mg/mL. Typical research dosing ranges from 1-6mg per week, often administered in divided doses. Due to its extended half-life, Mazdutide is typically administered once weekly in clinical research protocols. It is recommended to store the reconstituted peptide in a refrigerator (2-8°C) and use within 28 days to maintain peptide integrity. For optimal research outcomes, administer on an empty stomach.

For researchers investigating comprehensive metabolic protocols, combining Mazdutide with complementary compounds can yield synergistic insights. Consider exploring the following Dragon Pharma products to enhance your research:

• Cagrilintide Acetate: An amylin analog studied in combination with dual GLP-1/GIP agonists for enhanced metabolic outcomes.
• Survodutide: A glucagon/GLP-1 dual agonist for comparative research on multi-receptor metabolic modulation.
• AOD 9604: A lipolytic peptide fragment studied for its complementary effects on fat metabolism.

Third-Party Lab Results

2024-09-13

View Certificate

9.11 mg

Shipping & Authenticity

• From USA Domestic warehouse: 2-5 business days.
• From International warehouse: 14-21 business days.
• Free and automatic re-shipping policy if package doesn't reach destination within 30 days.
• Original product directly from manufacturer.
• We accept credit cards and cryptocurrency—crypto payments receive an additional 20% discount at checkout.

Storage Instructions

To maintain maximum stability and potency of the lyophilized powder, store the unopened vial in a freezer at -20°C (-4°F) away from light. Upon reconstitution with bacteriostatic water, the solution must be stored in a refrigerator at 2-8°C (36-46°F) and should be used within 28 days. Avoid repeated freeze-thaw cycles as this may degrade the peptide structure.

Frequently Asked Questions